Showing 13,401 - 13,420 results of 102,485 for search '(( 50 ((mean decrease) OR (teer decrease)) ) OR ( 5 ((step decrease) OR (a decrease)) ))', query time: 1.69s Refine Results
  1. 13401
  2. 13402
  3. 13403
  4. 13404
  5. 13405
  6. 13406
  7. 13407
  8. 13408

    <i>l</i>-THP decreased level of NO, ONOO<sup>−</sup> and iNOS, regulated expression of p85, eNOS and Akt. by Yi Han (194901)

    Published 2013
    “…(<b>g</b>) iNOS expression of myocardial I/R rats treated with vehicle and <i>l</i>-THP (M). iNOS expression was significantly decreased in <i>l</i>-THP (M)-treated group, <sup>###</sup>P<0.001 vs. sham group, *P<0.05 vs. vehicle group, n = 5. …”
  9. 13409
  10. 13410
  11. 13411

    Silencing GRK2 and GRK3 attenuate C3aR desensitization but GRK5 and GRK6 do not. by Qiang Guo (218747)

    Published 2013
    “…<p>(A) shRNA control, (B) GRK2, (C) GRK3, (D) GRK5 and (E) GRK6 KD cells were loaded with Indo-1 (1 µM), stimulated with C3a (100 nM) for 5 min and intracellular Ca<sup>2+</sup> mobilization was determined (black solid lines). …”
  12. 13412
  13. 13413

    Multiple homologs of 16p12.1 genes contribute to neurodevelopmental defects in <i>Drosophila melanogaster</i> and <i>X</i>. <i>laevis</i>. by Lucilla Pizzo (2735491)

    Published 2021
    “…<i>laevis</i> represents controls injected with the highest amount of morpholino (50 ng, see <b><a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009112#pgen.1009112.s005" target="_blank">S5 Fig</a></b>). …”
  14. 13414
  15. 13415
  16. 13416

    Median confidence factor at the end of the simulation decreases as war costs increase (line represents the median of 200 simulations for each level of war costs). by Dominic D. P. Johnson (215994)

    Published 2011
    “…Note, however, that this decrease would be offset by altering other settings of the model, such as increasing the attack threshold, <i>w</i>, above 0.5, or allowing the spoils of victory to exceed the losses of defeat, instead of the current setup in which there is a zero-sum gain or loss of a province.…”
  17. 13417
  18. 13418

    Data_Sheet_1_A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.PDF by Sofia Sandgren (17017017)

    Published 2023
    “…/mL (IQR 285.4) (p = 0.05); serum month 24: 6.7 pg/mL (IQR 4.7) (p < 0.01); serum month 60: 7.2 pg/mL (IQR 4.7) (p < 0.01)], compared to baseline [CSF: 1014 pg/mL (IQR 2832.5); serum 8.6 pg/mL (IQR 17.4)].</p>Conclusion<p>In this real-world mono-center population, we observed a progression-free survival of 69%, cumulative NEDA-3 of 33%, and reduced NfL levels, over a five-year follow-up. …”
  19. 13419
  20. 13420

    ET-26 hydrochloride (ET-26 HCl) has similar hemodynamic stability to that of etomidate in normal and uncontrolled hemorrhagic shock (UHS) rats by Bin Wang (30851)

    Published 2017
    “…</p><p>Methods</p><p>50% effective dose (ED<sub>50</sub>) and 50% lethal dose (LD<sub>50</sub>) were determined after single bolus doses of propofol, etomidate, or ET-26 HCl using the Bliss method and the up and down method, respectively. …”